✦ LIBER ✦

Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays

✍ Scribed by Daohai Zhang; Manuel Salto-Tellez; Elaine Do; Thomas Choudary Putti; Evelyn S.C. Koay

Book ID: 117818777
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 332 KB
Volume: 34
Category: Article
ISSN: 1532-8392
DOI: 10.1053/hupa.2003.60

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new high frequency polymorphism in the

A new high frequency polymorphism in the HER-2/neu oncogene in normal tissue and breast tumors

✍ William T. Briscoe; Durwood B. Ray; Janice L. Airhart; Anne L. Ratliff; Elizabet 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 454 KB

HER-2/neu receptor gene status in endome

HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study

✍ Mina Xu; Peter Schwartz; Thomas Rutherford; Mazu Azodi; Alexandro Santin; Dan Si 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

The HER-2/ neu Oncogene in Tumors of the

The HER-2/ neu Oncogene in Tumors of the Gastrointestinal Tract

✍ Ross, Jeffrey S.; McKenna, Barbara j. 📂 Article 📅 2001 🏛 Informa plc 🌐 English ⚖ 274 KB

Studies of the HER-2/neu Proto-Oncogene

Studies of the HER-2/neu Proto-Oncogene in Human Breast Cancer

✍ Dennis J. Slamon; William Godolphin; Axel Ullrich; Michael F. Press 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Assessment of Her-2/neu gene amplificati

Assessment of Her-2/neu gene amplification status in breast carcinoma with equivocal 2+ Her-2/neu immunostaining

✍ Naglaa A.E. Mostafa; Saad S. Eissa; Dalia M. Belal; Soheir H. Shoman 📂 Article 📅 2011 🏛 National Cancer Institute - Egypt 🌐 English ⚖ 933 KB

Prognostic and predictive value of HER2/

Prognostic and predictive value of HER2/neu oncogene in breast cancer

✍ Shahla Masood; Marilyn M. Bui 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

## Abstract Assessment of __HER2/neu__ oncogene has been used as both a prognostic and predictive marker for breast cancer. However, the choice of the best method to assess the status of __HER2/neu__ oncogene in breast cancer tissue remains controversial. A variety of techniques are available to de